Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Aug '25 Aug 4, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2020
Market Capitalization	97	25	22	10	-	-	Upgrade
Market Cap Growth	299.54%	15.55%	108.97%	-	-	-	Upgrade
Enterprise Value	118	38	33	57	-	-	Upgrade
Last Close Price	2.00	0.54	0.47	0.23	-	-	Upgrade
PE Ratio	28.11	6.53	-	-	-	-	Upgrade
PS Ratio	2.58	0.71	0.71	0.68	-	-	Upgrade
PB Ratio	2.71	0.83	0.81	0.32	-	-	Upgrade
P/TBV Ratio	2.71	0.83	0.81	0.32	-	-	Upgrade
EV/Sales Ratio	3.14	1.09	1.08	3.75	-	-	Upgrade
EV/EBITDA Ratio	11.68	4.57	-	-	-	-	Upgrade
EV/EBIT Ratio	12.25	4.60	-	-	-	-	Upgrade
Debt / Equity Ratio	1.11	1.25	1.26	0.66	-2.59	0.54	Upgrade
Debt / EBITDA Ratio	3.91	4.32	-	-	-	-	Upgrade
Asset Turnover	0.52	0.51	0.50	0.38	0.37	0.04	Upgrade
Quick Ratio	22.11	13.27	1.66	15.19	12.03	1.30	Upgrade
Current Ratio	22.36	13.43	1.69	15.46	13.31	1.30	Upgrade
Return on Equity (ROE)	13.68%	13.47%	-22.32%	-300.57%	-	-125.86%	Upgrade
Return on Assets (ROA)	8.33%	7.53%	-3.14%	-31.26%	-55.00%	-41.20%	Upgrade
Return on Capital (ROIC)	8.78%	8.09%	-3.38%	-33.46%	-60.06%	-60.67%	Upgrade
Return on Capital Employed (ROCE)	12.80%	12.20%	-	-	-	-	Upgrade
Earnings Yield	4.63%	15.31%	-30.37%	-278.74%	-	-	Upgrade
FCF Yield	-3.17%	-16.24%	-84.92%	-347.37%	-	-	Upgrade
Buyback Yield / Dilution	-20.45%	-16.21%	-34.59%	-55.01%	-29.25%	-	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.